Absolute lymphocyte count at Day 30 (not earlier) and early CRS predict delayed responses to teclistamab: Results from the US Myeloma Immunotherapy Consortium Meeting Abstract
| Authors: | Banerjee, R.; Kaur, G.; Razzo, B.; Portuguese, A.; Sidana, S.; Richards, T.; Grajales-Cruz, A.; Richard, S.; Shune, L.; Khouri, J.; Dima, D.; Lee, H.; Patel, K.; Vazquez-Martinez, M.; Hansen, D.; Davis, J.; Hashmi, H.; Atrash, S.; Ferreri, C.; Julian, K.; Herr, M.; Forsberg, P.; Cowan, A.; Anderson, L.; Garfall, A. |
| Abstract Title: | Absolute lymphocyte count at Day 30 (not earlier) and early CRS predict delayed responses to teclistamab: Results from the US Myeloma Immunotherapy Consortium |
| Meeting Title: | 21st Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 24 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 25-28 |
| Meeting Location: | Rio de Janeiro, Brazil |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | S43 |
| End Page: | S44 |
| Language: | English |
| ACCESSION: | WOS:001325737900070 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(24)01910-4 |
| Notes: | Meeting Abstract: P-007 -- Source: Wos |
